I am a medical doctor, with a master’s degree in business administration, and 更多 than 25 years’ experience in global and local development and commercialisation of pharmaceuticals. I worked across a number of disease areas including renal, diabetes, heart failure, Alzheimer’s disease, ophthalmics and Parkinson’s disease.

I joined AstraZeneca as Global Medicine Leader in our CVRM 文件夹 overseeing development of a diabetes medicine in 2015. Since then, I have taken on increasing responsibility and expanded my remit to include Vice President of the same medicine in 2017, followed by Vice President Diabetes Injectables in 2018, and most recently, as Global Medicine Leader – Vice President for an additional medicine in our Renal 文件夹 in 2019.  

I lead the worldwide development, registration, life cycle management, launch and commercialisation of the 产品介绍s I am responsible for. I have overseen the development, registration and US launch of a new formulation of a diabetes medicine and 更多 patient friendly diabetes device, in addition to delivering innovative life-cycle management programmes.

I am also involved in design and implementation of the renal disease area strategy and the 产品介绍 strategy for an investigational medicine in type-2 diabetes.

I earned my medical doctorate at the Université Louis Pasteur in Strasbourg, France, in 1991. For several years, I specialised in drug development while practising medicine and leading international projects for clinical research organisations.

From there, my interest in business led me to take an MBA in international business from the International University of America in San Francisco, California, in 1997. This was the year I joined Novartis where I remained for 19 years before joining AstraZeneca, holding positions of increasing responsibility, and gaining extensive registration and launch experience across disease areas and locations.

I like to overcome challenges, and, if possible, exceed expectations. I also enjoy learning new things along the way, and have plenty of opportunities to do that at AstraZeneca. Right now, there are a great number of opportunities for development at AstraZeneca. It’s very exciting, and the 文件夹 is just amazing.

Marie-José (MJ) Hoellinger, MD, MBA Global Product Leader & VP Commercial, Lokelma & Bydureon

lol世界总决赛下注平台

lols10比赛下注

lols10比赛下注

2017: AstraZeneca CEO Award lols10比赛下注


lols10外围押注

CURRENT ROLE

英雄联盟竞猜平台

英雄联盟竞猜平台

英雄联盟竞猜平台

英雄联盟竞猜平台

英雄联盟竞猜平台

Individualised treatment targets for elderly patients with type-2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study. lols10比赛下注

The Lancet, Volume 382, Issue 9890, Pages 409 - 416, 3 August 2013. Dr W David Strain MD, Valentina Lukashevich MD, Wolfgang Kothny MD, Marie-José Hoellinger MD, Päivi Maria Paldánius MMedSci.

英雄联盟竞猜平台

and help us deliver life-changing medicines 

Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.